mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |